Ultrasensitive.
No Compromise.
One immunoassay platform with breakthrough sensitivity, multiplex capability, and broad dynamic range — without giving up the ELISA workflow your lab already runs.
What Does "No Compromise" Actually Mean?
Scientists are used to making compromises.
ELISA
Familiar workflow, but low sensitivity, small dynamic range & large sample volume
High-sensitivity platforms
Better sensitivity, poor multiplexing, but low flexibility, complicated instrumentation and higher costs
Immuno-PCR systems
More analytes, but reduced assay performance and reliability
Multiple different platforms
Potentially viable, but requires additional development, validation, time and expense
Why Scientists Shouldn't Have to Choose
The Four No-Compromise Advantages
No Compromise on Sensitivity
Detect what others miss.
PFLISA delivers 50–1000x higher sensitivity leading to consistent femtogram-level LLOQs with low picogram single digit CV while preserving a familiar ELISA workflow.
No Compromise on Workflow
Keep the process. Improve the performance.
Move from multiplex screening to focus-plex or singleplex confirmation with validated multiplex panels without changing platforms, methods, instruments, or critical reagents.
No Compromise on Flexibility
One platform that adapts to your science.
Choose ready-to-run multiplex panels, create homebrew singleplex assays with your own reagents, or configure your own focus-plex panels from our validated antibody pairs.
No Compromise on Dynamic Range
Measure a wider range with one dilution.
PFLISA provides between 4 and 5 orders of magnitude of logarithmic dynamic range enabling studying a wider range of sample concentrations with one dilution on one plate.
Ultrasensitivity should not require a high-sensitivity budget
Breakthrough Performance
Lower Capital Investment
Reduced Operating Cost
Most Platforms Make You Sacrifice Something
PFLISA eliminates these trade-offs.
The Product Ecosystem
One Platform. Three Formats. Endless Possibilities.
PFLISA™ supports
the entire assay lifecycle on a single platform. No redevelopment. No revalidation. No compromise.
No Compromise
on
Sensitivity
50–1000x signal amplification with femtogram-level detection
No Compromise
on Workflow
Maintain the ELISA workflow your team already uses
No Compromise
on Flexibility
Multiplex, Singleplex and Focused-Plex on one platform
No Compromise
on
Dynamic Range
Measure a wider range of sample concentrations with one dilution
No Compromise
on Cost
High-performance immunoassays at lower capital cost
- 50x - 1000x lower LLOQ than traditional ELISA
- Consistent LLOQ for singleplex to multiplex
- Direct ELISA transfer with no optimization
- Single-digit CVs
- Robust signal stability
- Rapid in-house assay development
- Automation-friendly workflows
- Delivering ultrasensitive immunoassays without compromise
No compromise on Sensitivity. Workflow. Flexibility. Cost.
Get the performance today’s research demands without changing how your lab works.
Contact Us to find out how the PFLISA™ platform can revolutionise your immunoassay analysis